[1] LI W,SONG F,WANG X,et al. Relationship between metabolic syndrome and its components and cardiovascular disease in middle-aged and elderly Chinese population:a national cross-sectional survey[J].BMJ Open,2019,9(8):e027545. [2] TAO L X, YANG K, WU J, et al. Association between plasma homocysteine and hypertension: results from a cross-sectional and longitudinal analysis in Beijing's adult population from 2012 to 2017[J]. J Clin Hypertens (Greenwich), 2018, 20 (11): 1642-1632. [3] 陈泽.人体血清同型半胱氨酸水平和心血管疾病的相关性分析[J].临床医学研究与实践,2020,5(33):106-107. [4] 黄奕铭,谭爱花,张海英,等. 广西防城港市中年男性同型半胱氨酸与代谢综合征相关性分析[J].中国现代医药杂志,2019,21(7):9-12. [5] 王忠丽,张雪梅,郝志华,等. 事业单位中老年人血清同型半胱氨酸水平与代谢综合征的关系[J].临床研究,2020,34(11):1165-1169. [6] LEE H S, IN S, PARK T. The homocysteine and metabolic syndrome: a mendelian randomization study[J].Nutrients 2021,13(2440):1-11. [7] 冯胜强,刘岩,王亮,等. 老年人血清高敏C反应蛋白和同型半胱氨酸水平与代谢综合征关系的研究[J].2020,22(8):820-823. [8] SUNG S H, KIM N H, HONG S P, et al. Associations of metabolic syndrome with total testosterone and homocysteine levels in male korean workers[J]. Endocrinol Metab (Seoul),2019,34(2):158-168. [9] BALINT B, JEPCHUMBA V K, GUEANT J L, et al. Mechanisms of homocysteine-induced damage to the endothelial, medial and adventitial layers of the arteral wall[J].Biochimie,2020(173):100-106. [10] MANTOVANI A, BALLESTRI S, LONARDO A, et al. Cardiovascular disease and myocardial abnormalities in nonalcoholic fatty liver disease[J]. Dig Dis Sci, 2016, 61 (5): 1246-1267. [11] LI R, LI W, LUN Z, et al. Prevalence of metabolic syndrome in mainland china: ameta-analysis of published studies[J]. BMC Public Health, 2016, 16 (1): 296. [12] NIAZI E, SARAEI M, AMINIAN O, et al. Frequency of metabolic syndrome and its associated factors in health care workers[J]. Diabetes Metab Syndr, 2019, 1 (13): 338-342. [13] MITCHEELL A J, VANVAMPFORT D, SWEERS K, et al. Pervalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders-a systematic review and meta-analysis[J]. Schizophrenia Bulletin, 2013, 39(2): 306-318. [14] D'ETTORRE G, PELLICANI V, GRECOM, et al. Metabolic syndrome in shift health care workers[J]. Med Lav, 2019, 110 (4): 285-292. [15] YANG B, FAN S, ZHI X, et al. Prevalence of hyperhomocysteinemia in China: a systematic review and meta-analysis[J]. Nutrients, 2014, 7 (1): 74-90. [16] DAI Y, ZHU J, MENG D, et al. Association of homocysteine level with biopsy-proven non-alcoholic fatty liver disease: a meta-analysis[J]. J Clin Biochem Nutr, 2016(58): 76-83. [17] DAI H J, WANG W J, TANG X H, et al. Association between homocysteine and non-alcoholic fatty liver disease in Chinese adults: a cross-sectional study[J]. Nutr J, 2016, 15 (1): 102. [18] TESSARI P, CECCHET D, VETTORE M, et al. Decreased homocysteine trans-sulfuration in hypertension with hyperhomocysteinemia: relationship with insulin resistance[J]. J Clin Endocrinol Metab, 2018, 103 (1): 56-63. [19] PIAZZOLLA G,CANDIGLIOTA M,FANELLI M, et al. Hyperhomocysteinemia is an independent risk facor of atherosclerosis in patients with metabolic syndrome[J]. Diabetol Metab Syndr, 2019(11):87. |